Tomomi Ohishi

Statistics

Publications

Citations

134

H-Index

Active since

1982

Affiliations

Novartis (Japan)(Current)

Kyushu University

Tottori University

Jichi Medical University

Nara Medical University

Tomomi Ohishi is an author at Novartis (Japan) specializing in clinical pharmacology, heart failure pharmacotherapy, and angiotensin receptor neprilysin inhibition.

Publications per year

1982–2023

Publications

Diffusivity and solubility of hydrogen in Pd-Fe and Pd-V alloys

Y. Sakamoto, Tomomi Ohishi, E. Kumashiro et al. · Journal of the Less Common Metals · 1982 · 51 citations

Natural Sciences, Materials Engineering, Materials Science +12

Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study

Hiroyuki Tsutsui, Shin‐ichi Momomura, Yoshihiko Saito et al. · Journal of Cardiology · 2016 · 50 citations

Medicine, Cardiology, Pharmacology +17

Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction　― Baseline Characteristics and Treatment of PARALLEL-HF Trial ―

Hiroyuki Tsutsui, Shin-ichi Momomura, Yoshihiko Saito et al. · Circulation Journal · 2018 · 20 citations · Full text

Medicine, Cardiology, Pharmacology +16

Long-Term Treatment With Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction　― Open-Label Extension of the PARALLEL-HF Study ―

Hiroyuki Tsutsui, Shin‐ichi Momomura, Yoshihiko Saito et al. · Circulation Journal · 2023 · 13 citations · Full text

Medicine, Cardiology, Pharmacology +15

1–4 of 4